Pilot Study of Nursing Touch and Biobehavioral Stress
P-NAT-BIO
Pilot Study of Nurse-Administered Touch and Biobehavioral Stress Responses of Preterm Infants
1 other identifier
interventional
19
1 country
1
Brief Summary
Randomized cross-over clinical trial to determine the effect of a nurse-administered comforting touch intervention on the biobehavioral stress responses of preterm infants hospitalized in the neonatal intensive care unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2021
CompletedFirst Posted
Study publicly available on registry
September 1, 2021
CompletedStudy Start
First participant enrolled
September 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2022
CompletedResults Posted
Study results publicly available
February 18, 2025
CompletedFebruary 18, 2025
January 1, 2025
7 months
August 23, 2021
December 12, 2024
January 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Average Heart Rate -- During Intervention
heart rate in beats per minute will be measured using an external electrocardiogram monitor and averaged over the intervention or control period
during intervention or control period, approximately 20 minutes
Average Heart Rate -- Recovery
heart rate in beats per minute will be measured using an external electrocardiogram monitor and averaged over the intervention or control period
recovery, 30 minutes after intervention delivery or control period
Secondary Outcomes (4)
Average High-frequency Heart Rate Variability -- During Caregiving Episode
during caregiving episode that included either the nurse-administered touch intervention or was delivered as standard care, approximately 20 minutes
Average High-frequency Heart Rate Variability -- Recovery
recovery, 30 minutes after caregiving that included either the nurse-administered touch intervention or standard care
Average Frequency of Skin Conductance Responses -- During Caregiving Episode
during caregiving episode, approximately 20 minutes
Average Frequency of Skin Conductance Responses -- Recovery
recovery, 30 minutes after intervention delivery or control period
Study Arms (2)
Nurse-Administered Touch Intervention
EXPERIMENTALPreterm infants will receive the nurse-administered touch intervention during one episode of essential nursing care.
Standard Care
NO INTERVENTIONPreterm infants will receive one episode of essential nursing care delivered as standard care.
Interventions
The nurse-administered touch intervention is a bare-handed, comforting touch intervention administered during an episode of essential nursing care. The bedside nurse will cradle the infant's head with one hand, using the other hand to gently support the infant's lower body and legs in a flexed position. The touches will be administered for 1 minute at the start of the essential care episode, 30 seconds after the diaper change, and 1 minute at the conclusion of the care episode.
Eligibility Criteria
You may qualify if:
- Born prematurely between 27 and 30 weeks post-menstrual age.
- Born to mothers who are English-speaking and able to provide informed consent.
- No more than 10 days old at the time of enrollment.
You may not qualify if:
- Diagnosed with Grade III/IV intraventricular hemorrhage or other neurologic abnormality (e.g. seizure disorder) affecting sensory perception or motor function.
- Diagnosed with a congenital anomaly requiring surgery during the neonatal period.
- Receiving scheduled steroids or vasopressors.
- Skin conditions that preclude the attachment of sensors.
- Diagnosed with Neonatal Abstinence Syndrome or born to mothers with known illicit drug use, except marijuana, during pregnancy.
- Diagnosed with chromosomal abnormalities.
- Requiring special isolation with universal gloving for potentially infectious pathogens.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio State Universitylead
- Nationwide Children's Hospitalcollaborator
Study Sites (1)
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Marliese D. Nist
- Organization
- The Ohio State University College of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Marliese D. Nist, PhD
Ohio State University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The statistician performing the data analysis will be blinded to group.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 23, 2021
First Posted
September 1, 2021
Study Start
September 10, 2021
Primary Completion
April 20, 2022
Study Completion
May 17, 2022
Last Updated
February 18, 2025
Results First Posted
February 18, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share